Suchergebnisse - "Lenalidomide"

PubPharm (1.105)

31

Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6) : results from a randomised, phase 3 trial

enthalten in: The Lancet. Haematology | 2024

von Mai, E. | Goldschmid, H. | Miah, K. | +74

ErratumIn: Lancet Haematol. 2024 Feb 7;:. - PMID 38340740

32

Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone : Subanalysis of the randomized phase 3 ATLAS trial

enthalten in: British journal of haematology | 2023

von Kubicki, T. | Dytfeld, D. | Wróbel, T. | +22

33

Comparative efficacy of novel-drugs combined therapeutic regimens on relapsed/refractory multiple myeloma : a network meta-analysis

enthalten in: Hematology (Amsterdam, Netherlands) | 2023

von Chen, H. | Chen, H. | Zhou, Y. | +4

34

Network meta-analysis of efficacy of ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma

enthalten in: Hematology (Amsterdam, Netherlands) | 2023

von DerSarkissian, M. | Cranmer, H. | Dabora, J. | +5

35

Outcomes of Autologous Stem Cell Transplantation in Patients with Ultra-High-Risk Multiple Myeloma

enthalten in: Transplantation and cellular therapy | 2023

von Pasvolsky, O. | Ghanem, S. | Milton, D. | +17

36

Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens

enthalten in: Nature cancer | 2023

von Maura, F. | Boyle, E. | Coffey, D. | +34

37

Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma : A Multicenter Study from Türkiye

enthalten in: Turkish journal of haematology : official journal of Turkish Society of Haematology | 2023

von Tekinalp, A. | Gedük, A. | Akdeniz, A. | +19

38

Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma : BMT CTN 1401

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Chung, D. | Shah, N. | Wu, J. | +36

CommentIn: Clin Cancer Res. 2023 Dec 1;29(23):4703-4705. - PMID 37733765

39

Venous Thromboembolism Risk in Patients With Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination With Lenalidomide and Dexamethasone

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Loncharich, A. | Fiala, M. | Slade, M. | +7

40

Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients : a single centre experience from the GMMG-HD6 and -HD7 trials

enthalten in: BMC cancer | 2023

von Kauer, J. | Freundt, E. | Schmitt, A. | +7